¹Ì±¹ÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ½ÃÇè µðÀÚÀκ°(°³ÀÔ, °üÂû, È®´ë ¾×¼¼½º), ÀûÀÀÁõº°(¾Ï, ¼øÈ¯±â), À§»óº°, Áö¿ªº°, ºÎ¹®º° µ¿Çâ(2023-2030³â)
U.S. Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular), By Phase, By Region, And Segment Forecasts, 2023 - 2030
»óǰÄÚµå : 1301013
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå ¼ºÀå°ú µ¿Çâ

¹Ì±¹ÀÇ °¡»ó ÀÓ»ó½ÃÇè(Virtual Clinical Trials) ½ÃÀå ±Ô¸ð´Â 2030³â 75¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö 5.45%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ø°Ý ÀÇ·á ä¿ë, ÀÓ»ó½ÃÇè µ¥ÀÌÅÍ ¼öÁý °­È­¿Í ¿¬°üµÈ ȯÀÚ ´Ù¾ç¼º Çʿ伺, ÇコÄÉ¾î µðÁöÅÐÈ­ ÁøÀü µîÀÇ ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

°¡»ó ÆÐ·¯´ÙÀÓ ¼³¹® Á¶»ç´Â µðÁöÅÐ µµ±¸¸¦ »ç¿ëÇÏ¿© °í¿ëÀ» °¡¼ÓÈ­ÇÏ°í ºñ¿ëÀ» ÁÙÀÌ°í Æ÷°ý¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ȯÀÚ¿Í ÀÓ»ó½ÃÇè ¸ÅĪ´Â ¾Ï¼¾ÅͰ¡ ÀΰøÁö´É(AI) ÀÌ¿ëÀ» ½ÃÀÛÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº ÀüÀÚ Â÷Æ® ±¸Á¶È­µÈ ºÎºÐ°ú ±¸Á¶È­µÇÁö ¾ÊÀº ºÎºÐ ¸ðµÎ ȯÀÚ µ¥ÀÌÅ͸¦ ¼öÁýÇϰí ÀÚ°ÝÀ» °áÁ¤Çϸç ClinicalTrials.gov µ¥ÀÌÅͺ£À̽º ÇØ´ç ¿ÀÇ ½ºÅ͵ð¿Í ȯÀÚ¸¦ ÀÏÄ¡½Ãŵ´Ï´Ù. À̸¦ À§ÇØ ÀÚ¿¬ ¾ð¾î ó¸® ¹× ±âŸ AI Á¢±Ù¹ýÀ» »ç¿ëÇÕ´Ï´Ù.

±ÔÁ¦ ´ç±¹ÀÌ ÀÌÀü¿¡´Â ¾ö°ÝÇß´ø ÀÚ°Ý ¿ä°ÇÀ» È®´ëÇϱâ À§ÇØ ³ë·ÂÇϸ鼭 ¾Ï¿¡¼­ ÀÌ·¯ÇÑ Ã·´Ü ºÐ¼® µµ±¸ÀÇ Á߿伺Àº ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿äÀÎÀº ¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. COVID-19 ´ëÀ¯Çà °á°ú, ¿ø°Ý ÀÇ·á´Â ÃÖ±Ù ÀÌ¿ëÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Á¶»ç ¿¬±¸¿¡ ÀÚ±ÝÀ» Á¦°øÇÏ´Â ´ëºÎºÐ ½ºÆù¼­°¡ ȯÀÚ Áß½ÉÁÖÀǸ¦ °­Á¶Çϱ⠶§¹®ÀÔ´Ï´Ù.

ÀÓ»ó½ÃÇè¿¡ ȯÀÚ¸¦ µî·ÏÇϰí À¯ÁöÇÏ´Â °ÍÀ» ¹æÇØÇÏ´Â °¡Àå Å« Àå¾Ö Áß Çϳª´Â ȯÀÚ Áö¸®Àû À§Ä¡¿Í »çȸ °æÁ¦Àû °èÃþÀÔ´Ï´Ù. À̰ÍÀº ¿ø°Ý ÀÇ·á¿¡ ÀÇÇØ ´Ù·ç¾îÁö°í ȯÀÚ ´Ù¾ç¼ºÀÌ °³¼±µÉ ¼ö ÀÖ½À´Ï´Ù. À̰ÍÀº ƯÁ¤ Áý´Ü ƯÁ¤ Áúº´°ú ±× Áý´Ü ½ÃÇè ¾à¹° ÀáÀçÀû È¿°ú º¸´Ù Çö½ÇÀûÀÎ À̹ÌÁö¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ¿ø°Ý ÀǷḦ ÀÓ»ó ¿¬±¸¿¡ »ç¿ëÇϸé ȯÀÚ´Â ¿¬±¸ÀÚ»Ó¸¸ ¾Æ´Ï¶ó Ä¡·á¿¡ ÇØ´çÇÏ´Â ÀÇ»ç¿Í º¸´Ù È¿°úÀûÀ¸·Î ±³·ùÇÒ ¼ö ÀÖ½À´Ï´Ù.

À¯ÇàÇÐÀº ¿¬±¸ ´ë»óÀÌ Å¬¸®´Ð °¡Á¤À¸·Î ¿Å°ÜÁö°í ¿¬±¸ÀÚ´Â µ¥ÀÌÅÍ ¼öÁýÀ» À§ÇÑ »õ·Î¿î ¹æ¹ýÀ» °ËÅäÇÏ°Ô µÇ¾ú½À´Ï´Ù. FDA´Â ½ÉÀü°è ¹× ½ºÆÄÀ̷ιÌÅÍ µî ȯÀÚ¸¦ ¿ø°Ý ¸ð´ÏÅ͸µÇϱâ À§ÇÑ ºñħ½À ÀÇ·á±â±â ¾×¼¼½º¸¦ ÀϽÃÀûÀ¸·Î ´Ã¸®´Â Áö½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¿¬±¸ÀÚµéÀº ƯÈ÷ Á¾¾çÇÐ Æò°¡ ºóµµ¸¦ º¯°æÇß½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ȯÀÚ º¸°í¼­¸¦ ÅëÇÑ °á°ú¸¦ ÃøÁ¤ÇÏ°í ½Ç¼¼°èÀÇ µ¥ÀÌÅ͸¦ ÀÛ¼ºÇÏ´Â ¿¬±¸ ´É·ÂÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â °¡»ó Æò°¡ÆÇ Á¢±Ù¹ý¿¡ ÀûÇÕÇÕ´Ï´Ù. ¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀåÀº À¯Çà¿¡ º¸´Ù ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå ¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå : ¿¬±¸ µðÀÚÀÎ ÃßÁ¤, µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå : ÀûÀÀÁõ ÃßÁ¤°ú ÃßÁ¤, µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå : ´Ü°è ÃßÁ¤, µ¿Ç⠺м®

Á¦7Àå ¹Ì±¹ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå : Áö¿ª ºÐ¼®

Á¦8Àå °æÀï ±¸µµ

NJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Virtual Clinical Trials Market Growth & Trends

The U.S. virtual clinical trials market size is expected to reach USD 7.52 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 5.45% from 2023 to 2030. Factors such as the adoption of telehealth, the need for patient diversity clubbed with enhanced data collection in clinical trials, and the increasing digitalization in healthcare are factors driving the growth of the market.

In a virtual paradigm, researchers can use digital tools to speed up hiring, cut down on overheads, and increase inclusivity. For patient-trial matching, for instance, cancer centers are starting to use artificial intelligence (AI). These platforms collect patient data from both structured and unstructured parts of electronic medical records, determine eligibility, and match patients to pertinent open studies in the ClinicalTrials.gov database. They use natural language processing and other AI approaches for this purpose.

The importance of these cutting-edge analytics tools in cancer is rising rapidly, as regulators work to enlarge previously stringent eligibility requirements. This factor is representing lucrative growth opportunities for the virtual clinical trials market in the United States. As a result of the COVID-19 pandemic, telemedicine has seen a sharp increase in usage in recent years. This is because most of the sponsors funding research studies have placed a greater emphasis on patient-centricity.

One of the biggest obstacles to patient enrollment and retention in clinical trials is the patient's geographic location and/or socioeconomic class. This is addressed via telemedicine, which also improves the possibility of better patient diversity. This provides a more realistic picture of a certain illness in a population and the potential effects of an investigational drug on that population. Furthermore, patients can interact with researchers as well as the treating doctors more effectively, when telemedicine is used in clinical research.

The pandemic switched research attention from study clinics to homes, leading researchers to consider novel methods for data gathering. The FDA published instructions to temporarily increase access to noninvasive medical devices for remote patient monitoring, such as electrocardiographs and spirometers. Researchers have changed the assessment frequency specifically in oncology. These developments are compatible with the virtual trial approach, which aims to increase the ability of studies to gauge patient-reported outcomes and produce real-world data. The U.S. market for virtual clinical trials has observed notable growth due to the pandemic.

U.S. Virtual Clinical Trials Market Report Highlights

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, and Scope

Chapter 4. U.S. Virtual Clinical Trials Market: Study Design Estimates & Trend Analysis

Chapter 5. U.S. Virtual Clinical Trials Market: Indication Estimates & Trend Analysis

Chapter 6. U.S. Virtual Clinical Trials Market: Phase Estimates & Trend Analysis

Chapter 7. U.S. Virtual Clinical Trials Market: Regional Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â